| Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apo B | cis | Discovery | rs520354 | 2:21,259,612 | A/G | 0.47 | 996 | 0.303 | 0.042 | 6.9×10-13 | 1.110 | 6.6×10-13 | 2.5×10-12 |
| Apo B | cis | Replication | rs679899 | 2:21,250,914 | A/G | 0.47 | 337 | -0.219 | 0.068 | 0.001 | -1.110 | 0.001 | 0.006 |
| Target (abbrv.) | Apo B |
| Target (full name) | Apolipoprotein B |
| Somalogic ID (Sequence ID) | SL000020 (2797-56_2) |
| Entrez Gene Symbol | APOB |
| UniProt ID | P04114 |
| UniProt Comment |
|
| Targeted by drugs (based on IPA annotation) |
|
| Biomarker applications (based on IPA annotation) |
|
| Wiki Pathways |
|
| Pathway Interaction Database |
|
| Reactome |
|
All locus annotations are based on the sentinel SNP (rs520354) and 3 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
| Genes hit or close-by |
|